What are the signs of MDS progression?
MDS generally refers to myelodysplastic syndromes. In most cases, signs of worsening myelodysplastic syndrome include anemia, bleeding tendency, increased susceptibility to infections, bone pain, and enlargement of the spleen and liver. Patients should seek timely medical care at a正规 hospital and receive treatment based on their specific condition. Detailed analysis is as follows:
1. Anemia
Patients with myelodysplastic syndromes often suffer from anemia because abnormal hematopoietic cells fail to differentiate properly into healthy red blood cells. Anemia may lead to symptoms such as fatigue, weakness, dizziness, and shortness of breath. Under medical guidance, patients may receive red blood cell transfusions to improve their anemic condition.
2. Bleeding Tendency
Abnormal platelet production can lead to a tendency to bleed. Patients may easily develop skin bruising, nosebleeds, or gum bleeding. This occurs due to insufficient platelet count or impaired platelet function, which hampers effective hemostasis. However, this can be improved under medical advice through platelet transfusions.
3. Increased Susceptibility to Infections
Due to impaired normal hematopoiesis in the bone marrow, patients with myelodysplastic syndromes may have reduced white blood cell counts, leading to weakened immune function and an increased risk of infection. Recurrent or persistent infections may indicate disease progression. Under a doctor’s guidance, patients may take medications such as amoxicillin-clavulanate potassium tablets, cefixime dispersible tablets, or amphotericin peptide tablets to alleviate symptoms.
4. Bone Pain
Myelodysplastic syndromes may affect the bone marrow membrane, causing bone pain. This pain commonly occurs in areas such as the sternum, spine, and pelvis, and may be a sign of disease progression. Patients may seek treatment at a正规 hospital, including allogeneic hematopoietic stem cell transplantation.
5. Enlargement of the Spleen and Liver
As the disease worsens, patients may develop splenomegaly and hepatomegaly. This results from excessive proliferation and accumulation of abnormal hematopoietic cells in the bone marrow, leading to organ dysfunction. Under medical supervision, patients may be treated with medications such as lenalidomide capsules, thalidomide tablets, or azacitidine for injection.
Patients are advised to consume high-protein, easily digestible, and nutrient-rich foods, maintain good hygiene practices to reduce the risk of contact infections, and avoid strenuous activities to minimize the risk of bleeding.